Study to Evaluate Use of Albuterol Multidose Dry Powder Inhaler With an eModule in Participants With Asthma

- Asthma
- Completed

Study Title: A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Teva Identifier: ABS-AS-30064

ClinicalTrials.gov Identifier: NCT02969408

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol Sulfate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years and older

Trial Duration: February 13, 2017 - February 2, 2018

Phase: Phase 3

Study Type

Interventional